Replies to post #114562 on Biotech Values

[10nisman]

I think that question highlights the issue. It is one thing to say that the company wants broad partnerships with large players. But when they are inking no deals with anyone for so long it leads to questions about the value of what MNTA has to offer.

What I would like to know is whether MNTA previously received interest in M118 and turned down any partnership(s) based on terms or whether no interest was received? Also, does inking a low value deal for M118 hurt future deals for other products?

10nis